LS

Len Schleifer

Person

Heard in 6 episodes across 1 show since Nov 2025

Len Schleifer is an American physician and biotechnology executive who has served as president and chief executive officer of Regeneron Pharmaceuticals since 1998.

Email alerts

Episodes

6
across 1 show

First heard

Nov 2025

Guest appearances

1

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20251
Dec 20251
Jan 20261
Feb 20260
Mar 20260
Apr 20260
May 20261
Jun 20260
Jul 20261
Aug 20260
Sep 20261
Oct 20260

Email alert

Email me when Len Schleifer comes up on a podcast

One email a week at most, with the new episodes that mention Len Schleifer. Free, no account needed, unsubscribe in one click.

What Len Schleifer has said on podcasts

8 statements

  1. on DupixentPositiveJan 14, 2026· Mad Money w/ Jim Cramer

    Dupixent is approved for eight indications and leads seven markets.

    “it's approved for eight different indications. And it's the leading drug in seven of those eight.”

    Listen at 25:23

    Open the episode · Mad Money w/ Jim Cramer 1/13/26
  2. on Eylea HDPositiveJan 14, 2026· Mad Money w/ Jim Cramer

    Eylea HD appears to be the most durable anti-VEGF product.

    “HD seems to be the most durable product in the field of anti-VEGF therapy for these blinding retinal diseases.”

    Listen at 26:20

    Open the episode · Mad Money w/ Jim Cramer 1/13/26
  3. on LibtayoPositiveJan 14, 2026· Mad Money w/ Jim Cramer

    Libtayo lowered recurrence risk by 68 percent in an adjuvant study.

    “we showed a dramatic improvement, 68 percent lowering of the risk of this cancer coming back.”

    Listen at 27:46

    Open the episode · Mad Money w/ Jim Cramer 1/13/26
See all 8 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

6 episodes featuring Len Schleifer, newest first